We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$390B
AUM Growth
-$191M
Cap. Flow
-$3.82B
Cap. Flow %
-0.98%
Top 10 Hldgs %
20.94%
Holding
4,210
New
290
Increased
1,777
Reduced
1,865
Closed
140

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$784M
2
NVDA icon
NVIDIA
NVDA
+$532M
3
AAPL icon
Apple
AAPL
+$491M
4
AMZN icon
Amazon
AMZN
+$438M
5
NEM icon
Newmont
NEM
+$399M

Sector Composition

Rank Sector Weight
1 Technology 24.71%
2 Financials 11.26%
3 Healthcare 8.31%
4 Industrials 8.25%
5 Consumer Discretionary 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APPN icon
3701
Appian
APPN
$1.98B
$268K ﹤0.01%
+8,121
New +$290K
GNTY
3702
DELISTED
Guaranty Bancshares
GNTY
$266K ﹤0.01%
7,689
ORGN
3703
DELISTED
Origin Materials
ORGN
$266K ﹤0.01%
6,926
-5,579
-45% -$212K
NVAX icon
3704
Novavax
NVAX
$1.2B
$266K ﹤0.01%
33,056
+16,299
+97% +$157K
UPST icon
3705
PUT
Upstart Holdings
UPST
$2.63B
$265K ﹤0.01%
+4,300
New +$268K
EEX
3706
DELISTED
Emerald Holding
EEX
$264K ﹤0.01%
54,700
RRR icon
3707
Red Rock Resorts
RRR
$3.77B
$261K ﹤0.01%
5,654
-274,002
-98% -$13.9M
FMS icon
3708
Fresenius Medical Care
FMS
$13.8B
$261K ﹤0.01%
11,528
-248
-2% -$5.38K
FSBC icon
3709
Five Star Bancorp
FSBC
$1.01B
$260K ﹤0.01%
+8,654
New +$271K
APGE icon
3710
Apogee Therapeutics
APGE
$10.1B
$259K ﹤0.01%
+5,710
New +$291K
BSTZ icon
3711
BlackRock Science and Technology Term Trust
BSTZ
$1.95B
$258K ﹤0.01%
12,444
+528
+4% +$10.9K
PKX icon
3712
POSCO
PKX
$16.1B
$257K ﹤0.01%
5,922
-265
-4% -$14.7K
OBK icon
3713
Origin Bancorp
OBK
$1.69B
$255K ﹤0.01%
7,670
SHLD icon
3714
Global X Defense Tech ETF
SHLD
$7.05B
$255K ﹤0.01%
+6,815
New +$263K
FCOM icon
3715
Fidelity MSCI Communication Services Index ETF
FCOM
$1.77B
$254K ﹤0.01%
+4,325
New +$250K
MKZR
3716
MacKenzie Realty Capital
MKZR
$2.32M
$253K ﹤0.01%
+8,022
New +$306K
BCH icon
3717
Banco de Chile
BCH
$20.9B
$253K ﹤0.01%
11,143
+302
+3% +$7.11K
CLDX icon
3718
Celldex Therapeutics
CLDX
$2.99B
$251K ﹤0.01%
+9,944
New +$270K
LGI
3719
Lazard Global Total Return & Income Fund
LGI
$236M
$251K ﹤0.01%
15,705
-584
-4% -$9.88K
WTAI icon
3720
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$587M
$251K ﹤0.01%
+11,388
New +$244K
ELEV
3721
DELISTED
Elevation Oncology
ELEV
$250K ﹤0.01%
444,039
+3,550
+0.8% +$2.1K
CRAI icon
3722
CRA International
CRAI
$1.16B
$249K ﹤0.01%
+1,330
New +$253K
BLW icon
3723
BlackRock Limited Duration Income Trust
BLW
$490M
$249K ﹤0.01%
17,603
-1,402
-7% -$20K
AVAH icon
3724
Aveanna Healthcare
AVAH
$2.04B
$248K ﹤0.01%
+54,375
New +$278K
PRAX icon
3725
Praxis Precision Medicines
PRAX
$8.58B
$248K ﹤0.01%
+3,227
New +$233K

Similar funds

Ameriprise's Q4 2024 Portfolio in Review

As of Q4 2024, Ameriprise held 4,210 positions worth $390B, down 0.05% from $390B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameriprise's Q4 2024 filing shows 290 new, 1,777 increased, 1,865 reduced and 140 closed positions. Its largest new stake was Primo Brands: 2,607,261 shares worth $80.2M. The largest sale was Elevance Health, an estimated $784M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q4 2024 buy was Primo Brands: 2,607,261 shares worth $80.2M.
  • Ameriprise added most to iShares Core US Aggregate Bond ETF in Q4 2024, an estimated $810M increase.
  • Ameriprise's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $784M.
  • Ameriprise fully exited Primo Water Corporation in Q4 2024, selling an estimated $62.3M.
  • Ameriprise's ten largest holdings make up 21% of its $390B portfolio in Q4 2024.
  • Ameriprise opened 290 new positions and closed 140 in Q4 2024.
  • Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $390B.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.